Boston Scientific shares saw a fund cut stake, concurrent with Bank of America dropping its price objective, following an SEC filing.
1 report, 1 independent
Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Boston Scientific shares saw a fund cut stake, concurrent with Bank of America dropping its price objective, following an SEC filing.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
-
Bank of America
American multinational banking and financial services corporation
Related events
- Boston Scientific announced major restructuring via filings with the NYSE and SEC on July 28, 2026.
- Financial institutions, including Wells Fargo and Bank of America, issued rating updates and filed reports regarding institutional stake reductions with the SEC.
- Eli Lilly and Company filed institutional holdings reports with the SEC, while Bank of America raised price targets on the stock.
- Boston Scientific filed an incident report with the SEC regarding a cyberattack and hired CrowdStrike to investigate.
- SpaceX received new financial coverage, filed share purchase disclosures, and saw its analyst rating lowered to 'hold'.